Skip to main content
Clinical Trials/NCT03881358
NCT03881358
Unknown
Not Applicable

Orthokeratology for High Myopia (OHM) Study

The Hong Kong Polytechnic University1 site in 1 country66 target enrollmentAugust 4, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myopia
Sponsor
The Hong Kong Polytechnic University
Enrollment
66
Locations
1
Primary Endpoint
Change in axial length elongation over 24 months.
Last Updated
5 years ago

Overview

Brief Summary

This project aims to investigate/examine high myopic subjects on full correction ortho-k (using Topaz ortho-k lenses for high myopia) compared to subjects undergoing partial reduction ortho-k and their relationship with myopia and myopic progression.

Detailed Description

For many years, commercially-available ortho-k lenses aim to reduce low - moderate myopia. Attempts to use these lenses for reduction of high myopia have been shown to give rise to complications such as corneal staining and lens decentration. Thus, practitioners may choose a more conservative way for high myopic children, that is, offering partial reduction ortho-k. Partial reduction ortho-k is target for 4.00-5.00D reduction and the residual refractive errors will be corrected with single vision spectacles to allow good visual acuity in the daytime. Partial reduction ortho-k has been shown to slow axial elongation in high myopic children, however, the main disadvantage is that the children have to wear spectacles in the daytime to correct residual refraction. Euclid has recently designed a new lens, Euclid's Topaz, for high myopic children. It is currently commercially available to correct myopia for up to 10 D. However, evidence of its effectiveness for visual correction and slowing AL growth is lacking. While numerous studies have shown that orthokeratology is an effective clinical treatment to slow axial eye growth in children, the exact mechanism underlying this reduction in myopia progression associated with orthokeratology remains unclear.

Registry
clinicaltrials.gov
Start Date
August 4, 2018
End Date
January 2024
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Pauline Cho

Professor

The Hong Kong Polytechnic University

Eligibility Criteria

Inclusion Criteria

  • Myopia: at least 5.00D in one eye or in both eyes
  • Astigmatism: ≤1.50D; with-the-rule astigmatism (axes 180 ± 30) ≤1.25D; astigmatism of other axes ≤0.50D in both eyes
  • Anisometropia: not be more than 1.00D in the former and not more than 2.00D in the latter.
  • Best-corrected Monocular Snellen visual acuity 6/7.5 or better

Exclusion Criteria

  • Strabismus at distance or near
  • Previous experience in contact lens wear or myopia control treatment (e.g. refractive therapy or progressive spectacles)
  • Contraindication for contact lens wear and orthokeratology (e.g. limbus to limbus corneal cylinder and dislocated corneal apex)
  • Previous history of ocular surgery, trauma, or chronic ocular disease
  • Concurrent use of medications that may affect tear quality or contact lens wear
  • Systemic or ocular conditions that may affect tear quality or contact lens wear (e.g allergy and concurrent medication) or that may affect refractive development (e.g Down syndrome, ptosis)
  • Poor compliance to tests (e.g poor fixation in noncontact tonometry or intolerance of lens wear)
  • Not willing to comply with the allocated treatment, use and care of lenses and follow-up schedule

Outcomes

Primary Outcomes

Change in axial length elongation over 24 months.

Time Frame: 2 years

To determine the change in axial length measured at baseline and two years after lens wear using IOLMaster

Secondary Outcomes

  • First fit success rate of a newly designed ortho-k lens for high myopic children(1 month)
  • Quality of life (questionnaire)(3 months)
  • Ocular aberration(2 years)

Study Sites (1)

Loading locations...

Similar Trials